Samsung Medical Center
| République de Corée | Turquie | Espagne | |
| Chirurgie de correction des déformations osseuses | de $8,200 | de $2,500 | de $15,000 |
| Chimiothérapie pour le cancer du sein | de $19,200 | de $1,200 | de $3,500 |
| Thérapie à l'actinium-225 | - | de $22,955 | de $45,000 |
| Résection osseuse | - | de $8,960 | de $20,000 |
| Radiothérapie pour le cancer colorectal | - | de $7,000 | de $10,000 |
Bookimed ne rajoute pas de frais pour les traitements de Cancer des os. Les tarifs proviennent des listes de prix officielles des cliniques. Vous payez directement à la clinique pour votre traitement à votre arrivée dans le pays.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans le traitement de Cancer des os et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de traitement de Cancer des os.
La Corée du Sud propose des traitements avancés contre le cancer des os axés sur la préservation des membres et la reconstruction biologique. Des centres spécialisés utilisent la thérapie par ions lourds, la chirurgie robotique et des conseils multidisciplinaires sur les tumeurs. Ces établissements accrédités par la JCI intègrent une chimiothérapie néoadjuvante à une précision chirurgicale pour maximiser les résultats fonctionnels pour les patients atteints de sarcome.
Avis d'expert Bookimed : Bien que de nombreux pays proposent des services d'oncologie, la Corée du Sud se distingue par la récupération fonctionnelle. Des cliniques comme le Seoul National University Hospital et le Samsung Medical Center traitent plus de 1 500 000 patients par an. Ce volume massif permet aux spécialistes d'affiner des techniques de reconstruction spécialisées que les hôpitaux généraux pratiquent rarement.
Consensus des patients : Les patients privilégient les oncologues orthopédiques spécialisés dans la résection conservatrice des membres plutôt que dans l'amputation. Ils demandent souvent un deuxième avis dans de grands hôpitaux universitaires pour s'assurer d'obtenir la meilleure capacité de marche possible et une rééducation à long terme.
La Corée du Sud rapporte un taux de survie à 5 ans pour le cancer des os localisé compris entre 60 % et 75 %. Les taux de réussite atteignent 80 % à 90 % pour le chondrosarcome de bas grade. Des établissements de premier plan comme l'hôpital de l'Université nationale de Séoul utilisent des protocoles de sauvetage des membres pour préserver la fonction et éviter l'amputation lors de l'ablation de la tumeur.
Avis d'expert Bookimed : L'hôpital Anam de l'Université de Corée est spécialisé dans la chirurgie sans transfusion sanguine et les techniques robotiques en oncologie. Cette précision permet souvent une récupération plus rapide après des résections complexes de sarcomes. Leur expertise en chirurgie de sauvetage des membres favorise une survie élevée tout en maintenant la qualité de vie du patient.
Consensus des patients : Les patients soulignent qu'il est essentiel de trouver une équipe spécialisée ayant de l'expérience dans les sarcomes. L'accent passe souvent de la simple survie à la réussite du sauvetage des membres et à la mobilité fonctionnelle à long terme.
Les meilleurs hôpitaux sud-coréens pour le traitement du cancer des os comprennent le Samsung Medical Center, le Seoul National University Hospital, l'Asan Medical Center et le Severance Hospital. Ces établissements accrédités par la Joint Commission International (JCI) utilisent des centres multidisciplinaires dédiés aux tumeurs musculo-squelettiques. Ils sont spécialisés dans les chirurgies complexes de sauvetage des membres et l'imagerie diagnostique avancée.
Avis d'expert Bookimed : Bien que de nombreux établissements proposent des services orthopédiques, le SNUH et le Severance Hospital se distinguent par leur histoire centenaire. Ces institutions ont été pionnières dans le traitement du cancer des os en Corée. Nos données montrent que le SNUH sert 10 700 patients par jour. Ce volume massif garantit que les chirurgiens maintiennent une expertise élevée dans les variantes rares de sarcomes.
Consensus des patients : Les patients notent que les meilleurs résultats pour les cancers des os rares proviennent des équipes spécialisées dans les sarcomes à Séoul. Ils insistent sur la recherche d'hôpitaux qui combinent chirurgie, radiothérapie et pathologie sous un même toit.
South Korean hospitals provide extensive support for bone cancer patients through dedicated international healthcare centres. Major Seoul facilities hold JCI accreditation and employ full-time English-speaking coordinators. These centres specialise in limb-salvage surgeries and high-precision radiation such as proton beam therapy.
Bookimed Expert Insight: South Korea's oncology landscape is dominated by massive 'digital hospitals' like Seoul National University Bundang Hospital. These centres treat up to 1.5 million patients annually. This extreme volume allows surgeons to specialise in ultra-rare bone sarcomas. A typical Australian specialist might only see these once a year.
Patient Consensus: Patients note that major university hospitals in Seoul provide excellent assistance through English-speaking staff. They recommend bringing physical pathology slides and unstained tumour material from Australia. Doing so avoids diagnostic delays.
South Korea reports 5-year survival rates for bone cancer. Localised paediatric osteosarcoma reaches 78% survival. Chondrosarcoma outcomes range between 80% and 90%. Ewing sarcoma survival stands at 75%. Major Seoul centres specialise in limb-preserving surgeries. This prioritises function while effectively removing tumours.
Bookimed Expert Insight: Speed of care is a distinct advantage in the Korean medical system. Korea University Anam Hospital offers same-day consultations and tests for new cancer cases. For Australians facing long specialist wait times, this accelerated diagnostic window can prevent disease progression. This efficiency allows surgeons to perform limb-sparing procedures before the bone structure is compromised.
Patient Consensus: Patients note that staying in Korea for treatment often feels more effective than returning home. They emphasise the importance of confirming the specific cancer subtype and stage early. This clarifies the outlook and total out-of-pocket costs before surgery begins.
Republic of Korea offers limb-sparing surgery for bone cancer. Specialists in Seoul prioritise preserving joint function using 3D-printed scaffolds and artificial prostheses. Major centres like Samsung Medical Center and Seoul National University Hospital employ multidisciplinary teams. They treat high-grade malignant bone tumours while avoiding amputation.
Bookimed Expert Insight: While many countries offer oncology, South Korea stands out for practical travel ease. Asan Medical Center provides free airport transfers and personal coordinators for international cases. This reduces logistical stress for Australians flying into Incheon. It is especially helpful when managing mobility issues common with bone tumours.
Patient Consensus: Patients value limb-sparing surgery because it avoids external prostheses. However, they note recovery involves intensive rehabilitation. The emotional benefit of preserving the limb in Korea often outweighs the trade-offs. These trade-offs include physical stiffness or future revision surgeries.
In South Korea, primary bone cancer treatment combines limb-sparing surgery with neoadjuvant chemotherapy. Surgeons prioritise removing tumours while preserving the limb using metal prostheses or biological bone grafts. Major Seoul centres employ multidisciplinary teams to manage complex cases like osteosarcoma and Ewing sarcoma.
Bookimed Expert Insight: South Korea is a global leader in digital oncology integration. Hospitals like Seoul National University Hospital have been fully digital since 2004. This allows international specialists to share high-resolution scans and pathology slides instantly. For Australian patients, this digital infrastructure simplifies getting a second opinion before flying to Seoul.
Patient Consensus: Patients note that Korean university hospitals require local re-testing of all pathology and biopsy slides before starting treatment. They often receive a multimodal plan including surgery, chemotherapy, and radiation for the best recovery.
South Korea provides specialised sarcoma care through dedicated musculoskeletal oncology centres at top university hospitals. Major institutions in Seoul utilise multidisciplinary teams. They also use technologies like proton beam therapy and robotic surgery. Facilities such as Samsung Medical Center and Asan Medical Center hold JCI and ISO accreditations.
Bookimed Expert Insight: Major Seoul hospitals offer elite care. However, wait times for initial consultations can vary significantly between institutions. Hospitals like Korea University Anam Hospital offer same-day consultations and tests for new cancer patients. This is a critical advantage for Australian patients. They need to start intensive treatment quickly without long stays in Seoul.
Patient Consensus: Patients advise bringing original pathology slides and clear imaging to Seoul. The orthopaedic oncology team will need them for mandatory re-assessment. International departments at top hospitals provide the necessary interpreter support. They also help navigate complex diagnostic requirements efficiently.
Bone cancer treatment in South Korea typically spans 6 to 9 months. This timeline includes diagnostic tests, surgical removal, and cycles of chemotherapy or radiation. Complex limb-salvage surgeries may extend rehabilitation for 12 months. Leading Seoul centres use PET-CT and proton beam therapy to streamline protocols.
Bookimed Expert Insight: South Korea's digital infrastructure significantly reduces administrative delays between diagnosis and surgery. At Korea University Anam Hospital, new cancer patients can receive consultations, diagnostic tests, and hospital admission. This can all happen on the same day. This efficiency can shorten the initial planning phase by several days. It is faster than other international hubs.
Patient Consensus: Patients report that active treatment in Korea lasts several months. They highlight the importance of factoring in recovery days between chemotherapy cycles. This is before returning to work or home to Australia.
Patients receive comprehensive follow-up care in South Korea through integrated hospital pathways. Major centres in Seoul provide structured monitoring, including scans and oncology reviews. This includes rehabilitation and multidisciplinary support. These services track recovery and manage any risk of recurrence after bone cancer surgery.
Bookimed Expert Insight: South Korean hospitals operate as massive digital ecosystems. Facilities such as Samsung Medical Center handle 2 million outpatients annually using integrated digital imaging systems. This allows doctors to share CT and MRI results in real-time. For Australian patients, this means follow-up scans are compared instantly against surgical records. The comparison detects minute changes.
Patient Consensus: Patients report that Korean hospitals provide fantastic support during recovery. They note that follow-up care is built into the hospital pathway, with staff assisting with documentation and return visit schedules.
Treatment teams in the Republic of Korea use a multidisciplinary approach for bone cancer. Specialists from orthopaedic oncology, medical oncology, and radiation oncology work together to design treatment plans. Major centres like Samsung Medical Center and Severance Hospital use pathologists and radiologists for precise staging and limb-salvage surgery.
Bookimed Expert Insight: Samsung Medical Center serves over 2,000,000 outpatients annually. It operates a cancer centre with 17 disease-specific departments. This high volume means their team sees more rare bone sarcoma cases than most Western hospitals. Their partnership with the Mayo Clinic ensures their protocols meet the highest global standards for complex oncology cases.
Patient Consensus: Patients find that care is highly coordinated around pathology confirmation and scans. International clinic staff provide essential English support in Seoul. Patients often recommend having all medical records translated into clear English. This helps the Korean specialists review previous treatments accurately.